Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
Understanding the role of HIV envelope conformation in modulating the elimination of infected cells by antibody-dependant cellular cytotoxicity
EF 2014-15
Résumé
Up until now, only one vaccine trial was able to provide partial protection against infection by the Human Immunodeficiency Virus type 1 (HIV-1). The study of the immune correlates provided by this vaccine trial revealed that a major part of this protection was due to immune effectors called antibodies. Antibodies are structures capable of binding specific parts of a pathogen. In the case of HIV-1, antibodies target an external viral component (envelope glycoproteins) involved in viral entry. In order to effectively infect cells, these external structures need to "open". Importantly, the "opening" of these envelopes exposes cryptic structures which can be bound by a particular class of antibodies, generated by vaccination or infection. Importantly, it is known that antibodies can mediate several functions once bound to their target, one of which being the recruitment and delivery of a signal to immune effectors cells to kill the infected cell and thus limit viral replication. Previous studies in the lab have shown that envelopes at the cell surface sampling this "open" conformation are more easily recognized by these antibodies which recruit effectors cells and result in the elimination of the infected cells. However, the virus developed sophisticated mechanisms to avoid "opening" its envelope glycoproteins at the surface of infected cells which could otherwise result in their elimination by this immune response. My project aims to use small molecules to force the "opening" of the envelopes expressed at the surface of HIV-1 infected cells to facilitate their elimination by this immune mechanism. The results generated by my project will help design new strategies aimed at decreasing HIV-1 transmission and/or eradicating the HIV-1 reservoir.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
331577
Name
Chapleau Jean-Philippe
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the role of HIV envelope conformation in modulating the elimination of infected cells by antibody-dependant cellular cytotoxicity
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibodies; Antibody-Dependant Cellular Cytotoxicity; Cell-Based Elisa; Envelope Conformational Changes; Flow Cytometry; Gp120; Hiv-1; Rv144; Small Molecules
Abstract
Up until now, only one vaccine trial was able to provide partial protection against infection by the Human Immunodeficiency Virus type 1 (HIV-1). The study of the immune correlates provided by this vaccine trial revealed that a major part of this protection was due to immune effectors called antibodies. Antibodies are structures capable of binding specific parts of a pathogen. In the case of HIV-1, antibodies target an external viral component (envelope glycoproteins) involved in viral entry. In order to effectively infect cells, these external structures need to "open". Importantly, the "opening" of these envelopes exposes cryptic structures which can be bound by a particular class of antibodies, generated by vaccination or infection. Importantly, it is known that antibodies can mediate several functions once bound to their target, one of which being the recruitment and delivery of a signal to immune effectors cells to kill the infected cell and thus limit viral replication. Previous studies in the lab have shown that envelopes at the cell surface sampling this "open" conformation are more easily recognized by these antibodies which recruit effectors cells and result in the elimination of the infected cells. However, the virus developed sophisticated mechanisms to avoid "opening" its envelope glycoproteins at the surface of infected cells which could otherwise result in their elimination by this immune response. My project aims to use small molecules to force the "opening" of the envelopes expressed at the surface of HIV-1 infected cells to facilitate their elimination by this immune mechanism. The results generated by my project will help design new strategies aimed at decreasing HIV-1 transmission and/or eradicating the HIV-1 reservoir.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chapleau, Jean-Philippe
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~